妈咪爱联合蓝光照射治疗新生儿黄疸的临床效果分析

Clinical Observation Analysis on the Curative Effect of Blue Light Irradiation Combined with Medilac-Vita in Treatment of Neonatal Jaundice

目的探讨妈咪爱联合蓝光照射治疗新生儿黄疸的临床效果。方法对照组患儿在接受常规治疗的同时,采用蓝光照射治疗;观察组患儿在此基础上加入妈咪爱治疗。结果两组黄疸患儿的黄疸高峰值存在一定的差异,其中,观察组患儿的黄疸高峰值集中在22 g·L^(-1)处;对照组患儿的黄疸高峰值集中在26 g·L^(-1)处。观察组与对照组患儿在进行联合治疗后血胆红素浓度均出现了下降;治疗后观察组患儿是血胆红素浓度为(65.62±9.51)μmol·L^(-1),低于对照组患儿平均(97.31±13.42)μmol·L^(-1)的浓度。结论在新生儿的黄疸治疗中妈咪爱联合蓝光照射治疗,能够降低患儿的黄疸高峰值以及患儿体内的血胆红素浓度。

Objective To explore the clinical effect of blue light irradiation combined with Medilac-vita in the treatment of neonatal jaundice. Methods 70 cases of neonatal jaundice patients in our hospital for treatment, according to the different method of treatment,they were divided into the observation group of 35 cases and the control group of 35 cases. The control group of neonates were in the conventional treatment as well as the usage of blue light irradiation treatment at the same time; the patients in the observation group were joined in the Medilac-vita treatment on this basis. Results There were some differences in the peak values of jaundice in the two groups of patients, among which the peak value of jaundice in the observation group was 22 g·L^-1; the peak value of jaundice in the control group was 26 g·L^-1. The levels of hemobilirubin in the observation group and the control group were decreased after the combination therapy.After treatment, the blood hemobilirubin concentration was（65.62±9.51） μmol·L^-1, which was lower than that of the control group（97.31±13.42） μmol·L^-1. Conclusion In the treatment of neonatal jaundice, blue light irradiation combined with Medilac-vita can reduce the high peak of jaundice and blood hemobilirubin concentration in neonates.